Insiders · Profile

Hyep Ivan

Chief Financial Officer at Bicara Therapeutics. Filing since 6 Oct 2025. CIK 0002034668

Company

Date

Role

Action

Shares

Amount

Of holding

BCAX Bicara Therapeutics Inc.

10 Aug 2026

Chief Financial Officer

Sold on a plan

12,500

$349.59K

8.8%

BCAX Bicara Therapeutics Inc.

8 Jul 2026

Chief Financial Officer

Sold on a plan

28,000

$807.67K

17.7%

BCAX Bicara Therapeutics Inc.

21 May 2026

Chief Financial Officer

Sold on a plan

9,200

$187.88K

6.0%

BCAX Bicara Therapeutics Inc.

21 Apr 2026

Chief Financial Officer

Sold on a plan

9,200

$211.61K

6.0%

BCAX Bicara Therapeutics Inc.

23 Mar 2026

Chief Financial Officer

Sold on a plan

9,200

$170.35K

6.0%

BCAX Bicara Therapeutics Inc.

4 Mar 2026

Chief Financial Officer

Sold on a plan

2,963

$54.06K

2.0%

BCAX Bicara Therapeutics Inc.

3 Mar 2026

Chief Financial Officer

Sold on a plan

13,555

$246.91K

8.5%

BCAX Bicara Therapeutics Inc.

22 Jan 2026

Chief Financial Officer

Sold on a plan

1,882

$34.16K

1.3%

BCAX Bicara Therapeutics Inc.

22 Dec 2025

Chief Financial Officer

Sold on a plan

9,200

$168.49K

6.0%

BCAX Bicara Therapeutics Inc.

24 Nov 2025

Chief Financial Officer

Sold on a plan

17,795

$330.09K

10.9%

BCAX Bicara Therapeutics Inc.

21 Nov 2025

Chief Financial Officer

Sold on a plan

605

$10.98K

0.4%

BCAX Bicara Therapeutics Inc.

9 Oct 2025

Chief Financial Officer

Sold on a plan

6,415

$116.93K

4.2%

BCAX Bicara Therapeutics Inc.

8 Oct 2025

Chief Financial Officer

Sold on a plan

5,627

$102.46K

3.7%

BCAX Bicara Therapeutics Inc.

7 Oct 2025

Chief Financial Officer

Sold on a plan

18,244

$332.39K

11.2%

BCAX Bicara Therapeutics Inc.

6 Oct 2025

Chief Financial Officer

Sold on a plan

6,514

$118.36K

4.3%

15 decisions on file.